Previous studies have suggested that p53 mediated autophagy might contribute to Dasatinib responsiveness in cancer cells.22 We therefore investigated whether p53 status was associated Dasatinib sensitivities in HCC cell lines. The gene discussed is TP53; the disease is hepatocellular carcinoma.